Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs
Journal of the American Chemical Society · 22.05.2024 · 146 (20) · 14203-14212
DOI: 10.1021/jacs.4c03238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 11.05.2024. Verfasst von Shun-Yu Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Fro…. Hauptthemen laut MEDLINE: Drug Carriers, Nanomedicine, Calixarenes, Antineoplastic Agents. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, NCC Fund.
Abstract (Originalsprache)
Nanomedicines often rely on noncovalent self-assembly and encapsulation for drug loading and delivery. However, challenges such as reproducibility issues due to the multicomponent nature, off-target activation caused by premature drug release, and complex pharmacokinetics arising from assembly dissociation have hindered their clinical translation. In this study, we introduce an innovative design concept termed single molecular nanomedicine (SMNM) based on macrocyclic carrier-drug conjugates. Through the covalent linkage of two chemotherapy drugs to a hypoxia-cleavable macrocyclic carrier, azocalix[4]arene, we obtained two self-included complexes to serve as SMNMs. The intramolecular inclusion feature of the SMNMs has not only demonstrated comprehensive shielding and protection for the drugs but also effectively prevented off-target drug leakage, thereby significantly reducing their side effects and enhancing their antitumor therapeutic efficacy. Additionally, the attributes of being a single component and molecularly dispersed confer advantages such as ease of preparation and good reproducibility for SMNMs, which is desirable for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Frontiers Science Center for New Organic Matter, Collaborative Innovation…
- College of Chemistry, Nankai University, Tianjin 300071, China.
- Xinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Sciences, Kashi University, Kashi 844000, China.
ORCID-Profile: Xin-Yue Hu, Kang Cai, Dong-Sheng Guo
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- NCC Fund
- Xinjiang Uygur Autonomous Region
Zitieren
APA
Yao, S. Y., Ying, A. K., Jiang, Z. T., Cheng, Y. Q., Geng, W. C., Hu, X. Y., Cai, K., & Guo, D. S. (2024). Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs. Journal of the American Chemical Society, 146(20), 14203-14212. https://doi.org/10.1021/jacs.4c03238
Vancouver
Yao SY, Ying AK, Jiang ZT, Cheng YQ, Geng WC, Hu XY, et al. Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs. Journal of the American Chemical Society. 2024;146(20):14203-14212. doi:10.1021/jacs.4c03238
BibTeX
@article{Yao2024,
author = {Yao, Shun-Yu and Ying, An-Kang and Jiang, Ze-Tao and Cheng, Yuan-Qiu and Geng, Wen-Chao and Hu, Xin-Yue and Cai, Kang and Guo, Dong-Sheng},
title = {Single Molecular Nanomedicines Based on Macrocyclic Carrier-Drug Conjugates for Concentration-Independent Encapsulation and Precise Activation of Drugs},
journal = {Journal of the American Chemical Society},
year = {2024},
volume = {146},
number = {20},
pages = {14203--14212},
doi = {10.1021/jacs.4c03238}
}
EUVIMED